Clinical Trials Logo

Clinical Trial Summary

Early endoscopy is an integral part of the management plan for patients presenting with clinical signs of severe or ongoing UGIB. An accurate endoscopic diagnosis and successful endoscopic hemostasis is highly dependent on adequate visualization of the entire gastric mucosa. Metoclopramide has previously been investigated as a prokinetic agent to aid gastric emptying prior to endoscopy, but its widespread adoption is limited by a lack of high quality clinical evidence as well as concerns regarding side effects. Erythromycin is currently the only prokinetic agent recommended by the American and the European guidelines for use in selected patients in order to reduce the need for second endoscopy. Its clinical application, however, is limited by risk of arrhythmia, significant drug interactions, and frequent drug shortages. Azithromycin is structurally related to erythromycin, but is devoid of most adverse side effects associated with erythromycin use. Early evidence suggests that azithromycin may be an effective alternative to erythromycin in the treatment of gastroparesis. The current study, an interventional, randomized, triple-blinded, placebo-controlled clinical trial, is primarily aimed to evaluate the effectiveness of azithromycin as a prokinetic agent in the management of UGIB. It is also aimed to further evaluate the role of metoclopramide as a prokinetic agent in this setting. Outcome measures to be collected in this study include the need for secondary endoscopy, overall mortality, transfusion requirement, length of stay, requirement for surgery, and incidence of adverse side effects. Results from this study would help identify a safe, effective, and readily available prokinetic agent to be used prior to endoscopy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03840057
Study type Interventional
Source Lifespan
Contact Waihong Chung, MD PhD
Phone 401-444-5280
Email waihong.chung@lifespan.org
Status Recruiting
Phase Phase 2
Start date July 1, 2020
Completion date July 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02537353 - Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic Hemoclip Phase 4
Recruiting NCT03624517 - Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices Phase 4
Suspended NCT03337256 - Direct Discharge of Patients With Upper Gastrointestinal Bleeding From the Emergency Department After Endoscopy N/A
Completed NCT04472364 - HemoPill Acute ® in Suspected Nonvariceal Upper Gastrointestinal Bleeding N/A
Completed NCT05563714 - Anticoagulation With Enhanced Gastrointestinal Safety N/A
Recruiting NCT00414713 - Transfusion Requirements in Gastrointestinal (GI) Bleeding Phase 4
Completed NCT03680950 - Efficacy Test of Real-Time Upper Gastrointestinal Monitoring System N/A
Completed NCT05085405 - Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS) Trial N/A
Recruiting NCT06077916 - Gastric CLEANsing by Intravenous AZithromycin in Urgent Endoscopy N/A
Recruiting NCT04902248 - OTSC vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal Bleeding N/A
Completed NCT02446678 - Use of PillCam ESO2 in Triaging Patients Present With Upper GIB N/A
Completed NCT05631639 - Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -A Pilot Study N/A
Completed NCT02978391 - UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD N/A
Completed NCT00045799 - Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill Phase 3
Recruiting NCT03090945 - Pediatric Acute Gastrointestinal Bleeding Registry
Recruiting NCT06192355 - Single-use Versus Reusable Gastroscopes in Patients With Upper Gastrointestinal Bleeding. N/A
Recruiting NCT06297954 - Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding Phase 3
Recruiting NCT03785080 - Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients N/A
Completed NCT03667703 - Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart Disease Phase 4
Terminated NCT02017379 - Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed. N/A